相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population--based cohort study
Shahab Abtahi et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Medications associated with fracture risk in patients with rheumatoid arthritis
Gulsen Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide
Hennie G. Raterman et al.
DRUGS & AGING (2019)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2019)
High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study
Tsung-Kun Lin et al.
CLINICAL EPIDEMIOLOGY (2018)
Efficacy of statins for osteoporosis: a systematic review and meta-analysis
T. An et al.
OSTEOPOROSIS INTERNATIONAL (2017)
DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable
Roy M. Fleischmann et al.
RMD OPEN (2017)
Association of Statins and Risk of Fractures in a Military Health System: A Propensity Score-Matched Analysis
Ian M. Ward et al.
ANNALS OF PHARMACOTHERAPY (2014)
Statins and Physical Activity in Older Men The Osteoporotic Fractures in Men Study
David S. H. Lee et al.
JAMA INTERNAL MEDICINE (2014)
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
G. Wells et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)